Review of 11 national policies for rare diseases in the context of key patient needs
Crossref DOI link: https://doi.org/10.1186/s13023-017-0618-0
Published Online: 2017-03-31
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dharssi, Safiyya https://orcid.org/0000-0002-9280-174X
Wong-Rieger, Durhane
Harold, Matthew
Terry, Sharon
Funding for this research was provided by:
Pfizer